SRPT
Sarepta Therapeutics Inc.
Company Overview
| Mkt Cap | $2.37B | Price | $24.01 |
| Volume | 4.51M | Change | +3.27% |
| P/E Ratio | 10.1 | Open | $23.42 |
| Revenue | $1.8B | Prev Close | $23.25 |
| Net Income | $235.2M | 52W Range | $10.42 - $138.81 |
| Div Yield | N/A | Target | $24.57 |
| Overall | 45 | Value | 40 |
| Quality | -- | Technical | 50 |
No chart data available
Stock Overview
Updated DailySarepta Therapeutics Inc. (SRPT) is a leading Healthcare company in the Biotechnology industry, currently trading at $24.01 with a market capitalization of $2.37 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows SRPT with a volume of 4.51 million shares. The stock opened up 0.73% from yesterday's close of $23.25. Current analyst estimates project earnings of $-3.45 per share for this year, with next year targeting $2.21.
SRPT demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including GILD, NVAX, RNA, PTCT, ALNY.
Key investment considerations for SRPT include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 2.3%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 06:35 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SRPT | $24.01 | +3.3% | 4.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Sarepta Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW